A Turning Point for Clinical Mass Spec? - Poll - MDSpire

A Turning Point for Clinical Mass Spec?

As Roche Diagnostics secures a first-of-its-kind CLIA designation, Allyson Kozak considers what it means for the future of clinical mass spectrometry

  • By

  • James Strachan

  • July 3, 2026

  • 6 min

Share

Original Source(s)

A Turning Point for Clinical Mass Spec?

  • by James Strachan

  • July 3, 2026

Related Content

Radial pulse harmonic analysis for cardiometabolic assessment: a computational and translational mini review

Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications

Editorial: Clinical Trials in Cardiovascular Medicine: 2025 — Addressing Residual Cardiovascular Risks Through Precision-Guided Approaches